Is this you? Create Your Porfile
Avatar

Russell Gotschall

Amicus Therapeutics

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Russell Gotschall is active.

Explore More

Publication

Featured researches published by Russell Gotschall.

Archive | 2017

Highly potent acid alpha-glucosidase with enhanced carbohydrates

Russell Gotschall; Hung V. Do

Neuromuscular Disorders | 2018

METABOLIC MYOPATHIES II

Yi Lun; Su Xu; Rebecca Soska; Anju Nair; Michelle Frascella; Anadina Garcia; A. Ponery; Jessie Feng; C. Della Valle; Russell Gotschall; Hung Do; Kenneth J. Valenzano; Richie Khanna

Molecular Genetics and Metabolism | 2018

A next-generation Fabry enzyme replacement therapy: A proprietary human α-galactosidase A co-formulated with a pharmacological chaperone, AT1001, shows greater substrate reduction than standard of care in Fabry mice

Su Xu; Adriane Schilling; Nestor Gomez; Michelle Frascella; Anandina Garcia; Rick L. Hamler; Daniel Ellsworth; Rebecca Soska; Anju Nair; Maria Cecilia Della Valle; Jessie Feng; Hayley Manger; Kenneth J. Valenzano; Hung Do; Russell Gotschall; Richie Khanna

Archive | 2017

Method for Selection of High M6P Recombinant Proteins

Hung V. Do; Russell Gotschall

Archive | 2017

Augmented Acid Alpha-Glucosidase For The Treatment Of Pompe Disease

Hung V. Do; Richie Khanna; Russell Gotschall

Neuromuscular Disorders | 2017

P.217 - Stabilized next-generation recombinant human acid alpha-glucosidase ATB200 clears accumulated glycogen and reverses cellular dysfunction to increase muscle strength in a mouse model of Pompe disease

Su Xu; Yi Lun; Anju Nair; Michelle Frascella; Anadina Garcia; Rebecca Soska; A. Ponery; Adriane Schilling; C. Della Valle; Jessie Feng; Russell Gotschall; Hung Do; Kenneth J. Valenzano; Richie Khanna

Molecular Genetics and Metabolism | 2017

Stabilized next-generation recombinant human acid alpha-glucosidase ATB200 clears accumulated glycogen and reverses cellular dysfunction to increase functional muscle strength in a mouse model of Pompe disease

Hung Do; Yi Lun; Su Xu; Rebecca Soska; Anju Nair; Michelle Frascella; Anadina Garcia; Adriane Schilling; Cecilia Della Valle; Jessie Feng; Russell Gotschall; Kenneth J. Valenzano; Richie Khanna

Molecular Genetics and Metabolism | 2017

A novel recombinant human acid alpha-glucosidase, ATB200, leads to greater substrate reduction and improvement in Pompe disease-relevant markers compared to alglucosidase alfa in GAA KO mice

Yi Lun; Su Xu; Rebecca Soska; Anju Nair; Michelle Frascella; Anadina Garcia; Russell Gotschall; Hung Do; Kenneth J. Valenzano; Richie Khanna

Molecular Genetics and Metabolism | 2016

Co-administration of the pharmacological chaperone AT2221 with a proprietary recombinant human acid alfa-glucosidase leads to greater plasma exposure and substrate reduction compared to alglucosidase alfa

Richie Khanna; Su Xu; Deborah Hilliard; Yi Lun; Adriane Schilling; Rebecca Soska; Anju Nair; Kate Chang; Jessie Feng; Michelle Frascella; Anadina Garcia; Kimberly Pendino; Franklin K. Johnson; Elfrida R. Benjamin; Russell Gotschall; Hung Do; Kenneth J. Valenzano

Molecular Genetics and Metabolism | 2015

Novel recombinant human acid α-glucosidase with optimal glycosylation is significantly better than standard of care enzyme replacement for glycogen clearance in skeletal muscles of GAA knock-out mice

Russell Gotschall; Su Xu; Yi Lun; Adriane Schilling; Rebecca Soska; Michelle Frascella; Anadina Garcia; Jessie Feng; Kate Chang; Nastry Brignol; Richie Khanna; Kenneth J. Valenzano; Hung Do

Explore More

Collaboration

Dive into the Russell Gotschall's collaboration.

Top Co-Authors
Avatar

Rick L. Hamler

University of Michigan

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge